Skip to content
FP
Company

Updated:

Foamix Pharmaceuticals Ltd.

Foamix Pharmaceuticals Ltd. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001606645, and its reported...

Overview

Foamix Pharmaceuticals Ltd. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001606645, and its reported industry is Medicinal Chemicals & Botanical Products. In 10-K filed on 2020-03-12, it reported annual revenue of USD 443,000; net income of USD -95,178,000; total assets of USD 81,159,000 for the fiscal period ended 2019-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

Company overview

Legal name
Foamix Pharmaceuticals Ltd.
Former names in filing history
Foamix Ltd. (2014-05-20 to 2014-08-13)
Classification
Company
Industry (SIC)
2833 — Medicinal Chemicals & Botanical Products
Headquarters
Rehovot, Israel
Incorporated in
L3
Fiscal year end
December 31
SEC CIK
0001606645

Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

Fiscal yearPeriod endRevenueNet incomeTotal assetsCash and equivalentsOperating cash flow
FY2019USD$443,000-$95.2M$81.2M$43.8M-$73.4M
FY2018USD$3.6M-$74.2M$103.7M$27.9M-$68.7M
FY2017USD$3.7M-$65.7M$80.3M$16.0M-$53.2M
FY2016USD$5.5M-$29.3M$135.6M$31.2M—

Recent SEC filings

FormFiledPeriodFiling
10-K10-K
8-K8-K
8-KFROM 8-K
8-KFORM 8-K
8-KFORM 8-K
8-KFORM 8-K
8-KFORM 8-K
8-KFORM 8-K
8-KFORM 8-K
10-Q10-Q
8-K8-K
8-K8-K

Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.

Research Foamix Pharmaceuticals Ltd. in Altss

Track this company’s investors, transactions and relationships in Altss.

Book a demo

More Company profiles

Foamix Pharmaceuticals Ltd. | Rehovot Company | Altss